1. Home
  2. LGVN vs SPGC Comparison

LGVN vs SPGC Comparison

Compare LGVN & SPGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • SPGC
  • Stock Information
  • Founded
  • LGVN 2014
  • SPGC 2018
  • Country
  • LGVN United States
  • SPGC United States
  • Employees
  • LGVN N/A
  • SPGC N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • SPGC
  • Sector
  • LGVN Health Care
  • SPGC
  • Exchange
  • LGVN Nasdaq
  • SPGC Nasdaq
  • Market Cap
  • LGVN 7.8M
  • SPGC 7.4M
  • IPO Year
  • LGVN 2021
  • SPGC 2023
  • Fundamental
  • Price
  • LGVN $4.39
  • SPGC $0.51
  • Analyst Decision
  • LGVN Strong Buy
  • SPGC
  • Analyst Count
  • LGVN 1
  • SPGC 0
  • Target Price
  • LGVN $12.00
  • SPGC N/A
  • AVG Volume (30 Days)
  • LGVN 24.5M
  • SPGC 79.8K
  • Earning Date
  • LGVN 08-09-2024
  • SPGC 08-15-2024
  • Dividend Yield
  • LGVN N/A
  • SPGC N/A
  • EPS Growth
  • LGVN N/A
  • SPGC N/A
  • EPS
  • LGVN N/A
  • SPGC N/A
  • Revenue
  • LGVN $978,000.00
  • SPGC $609,000.00
  • Revenue This Year
  • LGVN $137.24
  • SPGC $732.95
  • Revenue Next Year
  • LGVN $50.77
  • SPGC $142.00
  • P/E Ratio
  • LGVN N/A
  • SPGC N/A
  • Revenue Growth
  • LGVN N/A
  • SPGC 183.26
  • 52 Week Low
  • LGVN $0.77
  • SPGC $0.36
  • 52 Week High
  • LGVN $37.50
  • SPGC $30.00
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 71.83
  • SPGC 49.17
  • Support Level
  • LGVN $3.80
  • SPGC $0.45
  • Resistance Level
  • LGVN $6.40
  • SPGC $0.53
  • Average True Range (ATR)
  • LGVN 0.53
  • SPGC 0.06
  • MACD
  • LGVN 0.28
  • SPGC -0.00
  • Stochastic Oscillator
  • LGVN 59.31
  • SPGC 51.16

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About SPGC Sacks Parente Golf Inc.

Sacks Parente Golf Inc is a technology-forward golf company, with a growing portfolio of golf products, including putting instruments, golf shafts, golf grips, and other golf-related products. It designs, manufactures, and sells technology-forward, golf equipment, which is comprised of putting instruments, golf shafts, golf grips, and related product groups. It designs its golf products to fit golfers of all skill levels, amateur and professional. Its business segments currently include, golf putting instruments, golf shafts, and golf related products.

Share on Social Networks: